CD274 and neoplasm: The interaction of the programmed death receptor ligands 1 and 2 (PDL1/CD274 and PDL2/CD273) on tumor cells with PD-1 receptors on T cells leads to reduced T-cell activation and proliferation, thus enabling tumors to evade immune response (see Figure 1) [42].